Document is current
Any future updates will be listed below
-
Authors
Bode, David
Semmler, Lukas
Wakula, Paulina
Hegemann, Niklas
Primessnig, Uwe
Beindorff, Nicola
Powell, David
Dahmen, Raphael
Ruetten, Hartmut
Oeing, Christian
Alogna, Alessio
Messroghli, Daniel
Pieske, Burkert M.
Heinzel, Frank R.
Hohendanner, Felix http://orcid.org/0000-0002-0194-4615
-
Funding
Funding for this research was provided by:
Projekt DEAL
- License Information
-
More Information
Article History
Received: 4 August 2020
Accepted: 27 December 2020
First Online: 7 January 2021
Ethics approval and right to participate
: Animal experiments were approved by local authorities (G0317/17 and G0276/16).
: Not applicable.
: Lexicon Pharmaceuticals and Sanofi-Aventis provided sotagliflozin used for this study. D.P., employed by Lexicon Pharmaceuticals, as well as R.D. and H.R., employed by Sanofi-Aventis, have been involved in the development of sotagliflozin. The other authors have nothing to declare.
